Juliana Vergara

Juliana Vergara is an experienced professional in clinical development and research, currently serving as Associate Director at 89bio since May 2024. Prior experience includes a role as Principal Scientist at Senti Biosciences from September 2022 to May 2024, and Scientist I at Dana-Farber Cancer Institute from August 2019 to August 2022, with a focus on NK cell immunotherapies in clinical oncology. Juliana's early career involved clinical research in hepatology and emergency medicine, having worked at Clinicas Colsanitas and Hospital Pablo Tobón Uribe in 2019. Academic credentials include a Master of Medical Sciences in Clinical Investigation from Harvard Medical School and a Doctor of Medicine from Universidad de Antioquia.